Tredegar Current Assets
The Current Assets of Tredegar (TG) as of Jul 29, 2026 is 169.12 M USD. In the previous year, Current Assets was 139.83 M USD — a change of 20.95% (higher).
Get this data via API
Financial Data API
Current Assets
169.12 MUSD
YoY
20.95%
Last updated:
Current Assets of Tredegar is 2026 169.12 M USD. Current Assets of Tredegar was 2025 139.83 M USD. It decreases by 20.95% higher compared to the previous year.
Access this data via the Eulerpool API
Tredegar Stock analysis
What does Tredegar do? Tredegar Corporation is a multinational corporation based in the USA that operates in various business sectors. The company was founded in 1988 through the merger of Tredegar Industries and Crown Cork International.
The company is divided into three main business segments: Plastic Films, Aluminum Extrusions, and Healthcare. Within these segments, Tredegar offers a wide range of products and services for various applications.
The Plastic Films product line of Tredegar Corporation includes plastic films used in a variety of applications, including packaging films for food and medical devices, as well as films for the construction, electronics, and automotive industries. Tredegar also produces specialty films for applications that require high chemical resistance or high temperature resistance.
Tredegar's Aluminum Extrusions division manufactures aluminum profiles for a variety of applications, including window and door frames, ships, trucks and trailers, as well as solar power systems. They also produce foamed aluminum products that are lightweight yet durable, making them suitable for use in the automotive and construction industries.
Tredegar is also active in the healthcare sector and operates a subsidiary called "Nile Therapeutics." Nile develops and markets innovative drug-based therapies for cardiovascular diseases. The company has conducted several clinical trials and is currently in the late stage of developing a new drug called "Cenderitide" for the treatment of acute heart failure.
As a global company, Tredegar achieved sales of approximately $1.1 billion in 2020. The company is listed on the New York Stock Exchange and employs around 3,000 employees. Tredegar's products are used in various industries worldwide, and the company has production facilities in North America, Europe, and Asia.
Despite already having a wide range of products, the company is constantly making efforts to further develop and diversify its products. Recently, Tredegar announced its entry into the market for medical extrusion components to further expand its healthcare business.
Overall, Tredegar is a versatile and expanding company operating in different business sectors and offering a wide range of products. Its strategic focus on innovation and diversification will allow the company to solidify its position globally and generate future growth. Tredegar is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Tredegar stock
Current Assets of Tredegar is 169.12 M USD in 2026.
Access this data via the Eulerpool API
Balance Sheet — Tredegar
Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets
All Key Metrics — Tredegar
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth